Inventor
HERTING FRANK
DE13 patents
⚠️ This page may combine multiple inventors who share the name “HERTING FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
11 patentsUS7208491B2Apr 24, 2007
N-monoacylated o-phenylenediamines
HOFFMANN LA ROCHE19 citations92
US7098241B2Aug 29, 2006
Thiophene hydroxamic acid derivatives
HOFFMANN LA ROCHE27 citations92
US11525007B2Dec 13, 2022
Antibody fab and Fc variants
HOFFMANN LA ROCHE3 citations72
US7396944B2Jul 8, 2008
Thiophene derivatives, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE3 citations62
US11512133B2Nov 29, 2022
Methods for treating colon cancer or inhibiting cell proliferation by administering a combination of antibodies against human CSF-1R and antibodies against human PD-L1
HOFFMANN LA ROCHE0 citations60
US7638553B2Dec 29, 2009
Hydroxamates, their manufacture and use as pharmaceutical agents
HOFFMANN LA ROCHE0 citations51
US7501451B2Mar 10, 2009
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7423060B2Sep 9, 2008
Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
HOFFMANN LA ROCHE1 citations51
US7173060B2Feb 6, 2007
Oxime derivatives and their use as pharmaceutically active agents
HOFFMANN LA ROCHE0 citations51
US7071219B2Jul 4, 2006
Mono-acylated o-phenylendiamines derivatives
HOFFMANN LA ROCHE0 citations51
US7098247B2Aug 29, 2006
Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
HOFFMANN LA ROCHE0 citations41
ROCHE GLYCART AG
2 patentsUS9695233B2Jul 4, 2017
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG44 citations97
US10683345B2Jun 16, 2020
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
ROCHE GLYCART AG5 citations72